The findings from this latter study suggested that studying the expression of dysferlin protein in these more accessible cells could be a reliable method to diagnose dysferlinopathies and a valid alternative to muscle biopsy. This evidence concerns the gene DYSF and neuromuscular disease caused by qualitative or quantitative defects of dysferlin.